Thanks for that. I wasn't aware. She doesn't repond well to that regimen, so it doesn't apply to us. We should be alright. We're on track for the expanded acce

Thanks for that. I wasn't aware. She doesn't repond well to that regimen, so it doesn't apply to us. We should be alright. We're on track for the expanded access program. Also, it's a long story, but she was taken off an Irinotecan-containing regimen prematurely about a year ago. In hindsight, she was clearly reaponding very well to that particular drug, so we've got that in our toolkit.